Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local fluid paclitaxel delivery after bare-metal stenting in high-risk coronary restenosis
ChiCTR-TRC-12002484Phase 2Recruiting
- Sponsor
- Nil
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in coronary arteriosclerosis (2 arms), sponsored by Nil. Primary endpoint: Late lumen loss. Started Sep 2012; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002484.